Follow
Elizabeth Bilsland
Elizabeth Bilsland
Assistant Professor in Cell Biology, UNICAMP
Verified email at unicamp.br
Title
Cited by
Cited by
Year
Rck1 and Rck2 MAPKAP kinases and the HOG pathway are required for oxidative stress resistance
E Bilsland, C Molin, S Swaminathan, A Ramne, P Sunnerhagen
Molecular microbiology 53 (6), 1743-1756, 2004
2222004
Rck2 kinase is a substrate for the osmotic stress-activated mitogen-activated protein kinase Hog1
E Bilsland-Marchesan, J Ariño, H Saito, P Sunnerhagen, F Posas
Molecular and cellular biology 20 (11), 3887-3895, 2000
1862000
The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: what we (need to) know and how we can do so
DB Kell, PD Dobson, E Bilsland, SG Oliver
Drug discovery today 18 (5-6), 218-239, 2013
1602013
Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases
K Williams, E Bilsland, A Sparkes, W Aubrey, M Young, LN Soldatova, ...
Journal of the Royal society Interface 12 (104), 20141289, 2015
1502015
Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast
K Lanthaler, E Bilsland, PD Dobson, HJ Moss, P Pir, DB Kell, SG Oliver
BMC biology 9, 1-14, 2011
702011
Identification of putative regulatory upstream ORFs in the yeast genome using heuristics and evolutionary conservation
M Cvijović, D Dalevi, E Bilsland, GJL Kemp, P Sunnerhagen
BMC bioinformatics 8, 1-15, 2007
542007
Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan.
E Bilsland, L Van Vliet, K Williams, J Feltham, M Carrasco, W Fotoran, ...
Nature Publishing Group, 2018
462018
Functional expression of parasite drug targets and their human orthologs in yeast
E Bilsland, P Pir, A Gutteridge, A Johns, RD King, SG Oliver
PLoS Neglected Tropical Diseases 5 (10), e1320, 2011
432011
Yeast-based automated high-throughput screens to identify anti-parasitic lead compounds
E Bilsland, A Sparkes, K Williams, HJ Moss, M de Clare, P Pir, J Rowland, ...
Open Biology 3 (2), 120158, 2013
422013
Antiplasmodial and trypanocidal activity of violacein and deoxyviolacein produced from synthetic operons
E Bilsland, TA Tavella, R Krogh, JE Stokes, A Roberts, J Ajioka, ...
BMC biotechnology 18, 1-8, 2018
392018
Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains
M Chugh, C Scheurer, S Sax, E Bilsland, DA van Schalkwyk, KJ Wicht, ...
Antimicrobial agents and chemotherapy 59 (2), 1110-1118, 2015
392015
The Bre5/Ubp3 ubiquitin protease complex from budding yeast contributes to the cellular response to DNA damage
E Bilsland, M Hult, SD Bell, P Sunnerhagen, JA Downs
DNA repair 6 (10), 1471-1484, 2007
352007
Tails of histones in DNA double-strand break repair
E Bilsland, JA Downs
Mutagenesis 20 (3), 153-163, 2005
312005
Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi
E Bilsland, DM Bean, E Devaney, SG Oliver
PLOS Neglected Tropical Diseases 10 (1), e0004401, 2016
292016
Identification of novel modifiers of Aβ toxicity by transcriptomic analysis in the fruitfly
G Favrin, DM Bean, E Bilsland, H Boyer, BE Fischer, S Russell, ...
Scientific Reports 3 (1), 3512, 2013
242013
The protein kinases Rck1 and Rck2 inhibit meiosis in budding yeast
A Ramne, E Bilsland-Marchesan, S Erickson, P Sunnerhagen
Molecular and General Genetics MGG 263, 253-261, 2000
192000
Clinical and epidemiological aspects of feline leishmaniasis in Brazil
LS Neto, M Marcondes, E Bilsland, LVS Matos, MA Viol, KDS Bresciani
Semina. Ciências Agrárias, 1467-1480, 2015
14*2015
Contributions of Saccharomyces cerevisiae to Understanding Mammalian Gene Function and Therapy
N Zhang, E Bilsland
Yeast Systems Biology: Methods and Protocols, 501-523, 2011
142011
Genomic disruption of six budding yeast genes gives one drastic example of phenotype strain‐dependence
E Bilsland, M Dahlén, P Sunnerhagen
Yeast 14 (7), 655-664, 1998
141998
Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium falciparum and P. vivax
LT Ferreira, J Rodrigues, GC Cassiano, TA Tavella, KCP Tomaz, ...
Antimicrobial agents and chemotherapy 64 (9), 10.1128/aac. 02041-19, 2020
132020
The system can't perform the operation now. Try again later.
Articles 1–20